U.S. Special Operations Command (SOCOM), the organization that administers America’s Spec Ops forces, says it will soon start clinical trials of an “anti-aging pill” that could halt some naturally degenerative effects of aging.
The hope seems to be that these will make them bigger, stronger, and able to quickly recover from injuries in order to rejoin their comrades faster than would normally be the case with their untreated counterparts. Presumably, they're going to have to wait a while in order to assess the relative effects of the treatments.
“We have completed pre-clinical safety and dosing studies in anticipation of follow-on performance testing in fiscal year 2022,” Navy Commander Tim Hawkins, a SOCOM spokesperson, told Breaking Defense.
